Your browser doesn't support javascript.
loading
Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.
Fernlund, Anna; Jokubkiene, Ligita; Sladkevicius, Povilas; Valentin, Lil.
Afiliação
  • Fernlund A; Department of Obstetrics and Gynecology, Skåne University Hospital, Jan Waldenströms gata 47, 20502, Malmö, SE, Sweden. anna.fernlund@skane.se.
  • Jokubkiene L; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. anna.fernlund@skane.se.
  • Sladkevicius P; Department of Obstetrics and Gynecology, Skåne University Hospital, Jan Waldenströms gata 47, 20502, Malmö, SE, Sweden.
  • Valentin L; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Arch Gynecol Obstet ; 302(5): 1279-1296, 2020 11.
Article em En | MEDLINE | ID: mdl-32638095
PURPOSE: To identify predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding. METHODS: This was a planned secondary analysis of data from a published randomized controlled trial comparing expectant management with vaginal single dose of 800 µg misoprostol treatment of women with embryonic or anembryonic miscarriage. Predefined variables-serum-progesterone, serum-ß-human chorionic gonadotropin, parity, previous vaginal deliveries, gestational age, clinical symptoms (bleeding and pain), mean diameter and shape of the gestational sac, crown-rump-length, type of miscarriage, and presence of blood flow in the intervillous space-were tested as predictors of treatment success (no gestational sac in the uterine cavity and maximum anterior-posterior intracavitary diameter was ≤ 15 mm as measured with transvaginal ultrasound on a sagittal view) in univariable and multivariable logistic regression. RESULTS: Variables from 174 women (83 expectant management versus 91 misoprostol) were analyzed for prediction of complete miscarriage at ≤ 17 days. In patients managed expectantly, the rate of complete miscarriage was 62.7% (32/51) in embryonic miscarriages versus 37.5% (12/32) in anembryonic miscarriages (P = 0.02). In multivariable logistic regression, the likelihood of success increased with increasing gestational age, increasing crown-rump-length and decreasing gestational sac diameter. Misoprostol treatment was successful in 80.0% (73/91). No variable predicted success of misoprostol treatment. CONCLUSIONS: Complete miscarriage after expectant management is significantly more likely in embryonic miscarriage than in anembryonic miscarriage. Gestational age, crown-rump-length, and gestational sac diameter are independent predictors of success of expectant management. Predictors of treatment success may help counselling women with early miscarriage.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ocitócicos / Hemorragia Uterina / Abortivos não Esteroides / Aborto Incompleto / Misoprostol Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ocitócicos / Hemorragia Uterina / Abortivos não Esteroides / Aborto Incompleto / Misoprostol Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article